Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIEM Labs is a specialized healthcare company focused on the development and distribution of clinically-validated nutraceuticals and medical foods. The company is a leader in the management of histamine intolerance, providing the Diamine Oxidase (DAO) enzyme to the North American market under its Omne Diem brand. DIEM Labs collaborates with global ingredient innovators to formulate science-based solutions for complex metabolic and digestive conditions. Their product portfolio includes advanced delivery forms of folate and other condition-specific nutritional supports designed for healthcare practitioners and consumers. By bridging the gap between ingredient discovery and clinical application, DIEM Labs provides targeted interventions for patients with specific nutritional deficiencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIEM Labs.